However, it is important to ensure that people only use safe and high quality CBD products. https://www.eudebates.tv/ #eudebates #CBD #Cannabidiol #cannabis European Commission proposes unified EU vote on WHO cannabis scheduling recommendations In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations.
The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by the Council of Europe – the EU countries would vote as a block at the CND session in Vienna and the three motions the Commission supports stand a much higher chance of being approved.
One of these supported changes would be positive for the global cannabis industry: removing cannabis and cannabis resin from Schedule IV of the Single Convention on Narcotic Drugs (1961). Such a move would, in effect, recognize that cannabis and cannabis resin have medical value.
However, the Commission is proposing to postpone decisions on two other proposals and reject a third. Notably, the Commission asked for a “further assessment” on the proposed clarification that CBD preparations with no more than 0.2% THC not be subject to international control.
The CND has 53 members with a right to vote. They serve four-year terms. Thirteen of the 53 members will be EU countries by March 2020. If those 13 vote as a block, they will represent almost a quarter of the total votes within the CND. Commission on Narcotic Drugs In January 2019, the WHO submitted to the UN Secretary General six recommendations affecting the scheduling of different categories of cannabis products.
These were based on reviews done by the Expert Committee on Drug Dependence (ECDD), a technical body of the WHO that studies the risks and benefits of drugs. The Commission on Narcotic Drugs periodically updates its list of controlled substances and schedules based on the technical recommendations of the WHO. The CND might make changes based on those recommendations, but it can also decide not to accept the proposals, taking into account economic, political or social factors, for instance.
Is CBD legal? Hemp-derived CBD products with less than 0.3% THC are legal federally but still illegal under some state laws. Cannabis-derived CBD products, on the other hand, are illegal federally but legal under some state laws. Check local legislation, especially when traveling.
Also, keep in mind that the Food and Drug Administration (FDA) have not approved nonprescription CBD products, which may be inaccurately labeled. Benefits of CBD CBD is a popular natural remedy that people may use for a host of different health conditions.
There is growing evidence that CBD may be useful for: Pain relief People may use CBD to help manage different types of chronic pain. A 2017 study on rat models found that CBD injections reduced pain response to a surgical incision.
A 2020 study suggests that topical CBD may provide pain relief for those with peripheral neuropathy. Researchers found that CBD can significantly reduce intense pain, sharp pain, itchy sensations, and cold. Anxiety relief A 2015 study suggests that CBD is a potential treatment for multiple anxiety disorders, such as: post-traumatic stress disorder panic disorder generalized anxiety disorder social anxiety disorder obsessive-compulsive disorder A 2020 study also suggests that CBD may possess anxiolytic benefits, which means that it may be useful for mental health conditions, such as anxiety.
Cancer-related side effects CBD may help reduce cancer-related side effects, such as nausea and vomiting. A 2016study indicates that taking Sativex, a drug that contains CBD and tetrahydrocannabinol (THC), may provide relief from nausea and vomiting induced by chemotherapy.
Epilepsy In 2018, the Food and Drug Administration (FDA) approved Epidiolex, a purified form of CBD. A doctor may use Epidiolex to treat two rare forms of epilepsy in children: Lennox-Gastaut syndrome Dravet syndrome Researchers are beginning to understand how CBD may help manage seizures.
Neurodegenerative diseases A 2019 study suggests that CBD’s anti-inflammatory and antioxidant properties may also help manage neurodegenerative diseases, including: Parkinson’s disease Alzheimer’s disease Huntington’s disease amyotrophic lateral sclerosis Acne CBD has also shown promise in treating acne due to its anti-inflammatory properties and the ability to reduce sebum production.
A 2014 study suggests that CBD may prevent acne by inhibiting the sebaceous glands from secreting excess sebum. https://www.eudebates.tv/ #eudebates